iGMDRD152
Canonical SMILES: B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O
InChI: InChI=1S/C19H25BN4O4/c1-13(2)10-17(20(27)28)24-18(25)15(11-14-6-4-3-5-7-14)23-19(26)16-12-21-8-9-22-16/h3-9,12-13,15,17,27-28H,10-11H2,1-2H3,(H,23,26)(H,24,25)/t15-,17-/m0/s1
InChI Key: GXJABQQUPOEUTA-RDJZCZTQSA-N
Loading, please wait...
Standard Name | CHEMBL | Pubchem CID | KEGG Drug ID | DRUGBANK ID | Drug Status | Drug targets (TTD) | Drug Type |
|---|---|---|---|---|---|---|---|
Standard Name179324-69-7 CHEMBLCHEMBL325041 Pubchem CID387447 KEGG Drug IDD03150 DRUGBANK IDDB00188 Drug StatusAlone Drug targets (TTD)DAP001318 Drug TypeSmall Molecule | |||||||
Drug Class:
AcidsAcids, NoncarboxylicAntineoplastic AgentsAntineoplastic and Immunomodulating AgentsBoron CompoundsBoronic AcidsCardiotoxic antineoplastic agentsCytochrome P-450 CYP1A2 InhibitorsCytochrome P-450 CYP1A2 Inhibitors (moderate)Cytochrome P-450 CYP1A2 SubstratesCytochrome P-450 CYP2C19 InhibitorsCytochrome P-450 CYP2C19 Inhibitors (moderate)Cytochrome P-450 CYP3A InhibitorsCytochrome P-450 CYP3A4 InhibitorsCytochrome P-450 CYP3A4 Inhibitors (weak)Cytochrome P-450 Enzyme InhibitorsHeterocyclic CompoundsHeterocyclic Compounds, 1-RingHypotensive AgentsImmunosuppressive AgentsMyelosuppressive AgentsPotential QTc-Prolonging AgentsProteasome InhibitorsPyrazinesQTc Prolonging AgentsDrug-model tissue-cancer distribution: Bubble Plot
Drug-gene pathway enrichments
Drug-gene GO enrichments
Drug-Gene: Aster Plot
Gene in drug-gene network: Network Plot
Models in 179324-69-7
Loading, please wait...
Model | Level | Reference ID | Tissue | Cancer | Drug | Clinical Response | Source | |
|---|---|---|---|---|---|---|---|---|
| No matching records found | ||||||||
CLASSFICATION
Copyright © 2018 Modellab | All Rights Reserved
Disclaimer: iGMDR is intended for research purposes only. Its information cannot be used for emergencies or medical or professional advice.